Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
Toronto, Ontario--(Newsfile Corp. - January 23, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has closed its previously announced private placement of units (the "Units") of the Company (the "Offering"), including the full exercise of the over-allotment option. Canac
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-01-23 9:16 AM EST | Cardiol Therapeutics Inc.
Akanda Announces Closing of $7.0 Million Convertible Note Offering
Toronto, Ontario--(Newsfile Corp. - January 23, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced the closing of its previously announced transaction with institutional investors for the purchase and sale of 12 month, convertible promissory notes for an aggregate purchase price of $7.0 million, in a private placement transaction. The Company shall use the proceeds from the sale of the notes for (i) marketing purposes of up to $2.3 million, (ii) workin
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-01-23 8:00 AM EST | Akanda Corp
Simply Solventless Announces Acquisition of Brand Uncommon Cannabis Co., Provides Commercial Update, and Announces Conversion of $1.0 Million Promissory Notes to Equity at $0.20/Unit
Calgary, Alberta--(Newsfile Corp. - January 22, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to announce the acquisition of dried flower and preroll brand Uncommon Cannabis Co. ("Uncommon"), and that SSC has entered into an agreement to convert $1.0 million of promissory notes ("Notes") to equity at $0.20 per u
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-01-22 7:02 AM EST | Simply Solventless Concentrates Ltd.
Akanda Announces $7.0 Million Convertible Note Offering
Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced the execution of a securities purchase agreement with institutional investors for the purchase and sale of 12 month, convertible promissory notes for an aggregate purchase price of $7.0 million, in a private placement transaction. The closing of the transaction is expected to occur, subject to customary closing conditions, on January 21, 2026. The Com
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-01-20 8:00 AM EST | Akanda Corp
Simply Solventless Provides Update on Humble Grow Co. Retrofit & Status of Past Acquisition Integrations and Cost Savings
Calgary, Alberta--(Newsfile Corp. - January 19, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or "the Company") is pleased to provide updates regarding its previously announced cultivation facility retrofit by its wholly owned subsidiary, Humble Grow Co. ("Humble"), and the integration of past acquisitions and related cost savings achieved. Humble Retrofit Jeff Swainson, SSC's President & CEO stated: "All Humble retrofit L
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-01-19 7:02 AM EST | Simply Solventless Concentrates Ltd.
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has entered into an agreement with a sole underwriter and sole bookrunner pursuant to which the underwriter (the "Underwriter") has agreed to purchase for resale 10,384,616
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-01-16 8:46 AM EST | Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has entered into an agreement with Canaccord Genuity Corp. (the "Underwriter") as the sole underwriter and sole bookrunner pursuant to which the Underwriter has agreed to p
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-01-16 8:42 AM EST | Cardiol Therapeutics Inc.
Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run
Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched" or the "Company"), a life sciences company dedicated to developing and commercializing products derived from the Amanita Muscaria mushroom, is pleased to announce a key commercial milestone for its newest product, Calmer. The Company has officially sold out of its initial production run following strong early demand and positive consumer feedback.
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-01-15 12:42 PM EST | Psyched Wellness Ltd.
Captiva Verde Welcomes Greg Reitman as Chairman of the Captiva Verde Media and Charity Advisory Board
Coquitlam, British Columbia--(Newsfile Corp. - January 14, 2026) - Captiva Verde Wellness Corp. (CSE: PWR) (OTC Pink: CPIVF) (the "Company or Captiva") announces that it welcomes Greg Reitman as Chairman of the Captiva Verde Media and Charity Advisory Board. Greg is an American Film Director, Producer, Screenwriter, National Best-Selling Author & Founder of the Blue Water Institute and Blue Water Film Festival. About Greg Reitman Mr. Reitma
Agriculture, Cannabis, Cannabis Manufacturer
2026-01-14 9:00 AM EST | Captiva Verde Wellness Corp.
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
Toronto, Ontario--(Newsfile Corp. - January 13, 2026) - Cardiol Therapeutics Inc. (NASDAQ:
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-01-13 7:27 AM EST | Cardiol Therapeutics Inc.
Captiva Verde Wellness Corp. Announces Opening of Atmospheric Water Station in Florida
Coquitlam, British Columbia--(Newsfile Corp. - January 12, 2026) - Captiva Verde Wellness Corp. (CSE: PWR) (OTC Pink: CPIVF) (the "Company or Captiva") announces that it will co-host a significant atmospheric water station ribbon cutting ceremony on January 30, 2026 in Florida. Further details on the other institutional co-hosts and the location will be made shortly. The Company further announces that it has granted an aggregate of 5,000,000 incentive stock options (the "
Agriculture, Cannabis, Cannabis Manufacturer
2026-01-12 9:00 AM EST | Captiva Verde Wellness Corp.
Akanda Corp. Announces Reverse Stock Split
Toronto, Ontario--(Newsfile Corp. - January 8, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-5 reverse stock split of the Company's common shares effective January 12, 2026. The reverse stock split was previously approved by the Company's shareholders on November 28, 2025 and Board of Directors on December 23, 2025 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of marke
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-01-08 8:30 AM EST | Akanda Corp
1CM Announces CFO Change
Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM" or the "Company") is pleased to announce that its board of directors has appointed Antony Pramoth as Chief Financial Officer of the Company. Mr. Pramoth succeeds Harshil Chovatiya, who has served as the Company's Chief Financial Officer since February 24, 2023, effective immediately. Mr. Pramoth has been with 1CM since October 2023. The Company is pleased to promote Mr.
Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-01-07 5:21 PM EST | 1CM Inc.
SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan
Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased to announce that SNDL has completed the acquisition of 5 cannabis retail stores located in Alberta and Saskatchewan from 1CM. The transaction represents the completion of the first closing pursuant to the amended and restated arrangement agreement dated December 15, 2025 (the "
Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-01-07 4:43 PM EST | 1CM Inc.
Illicit Brand Parent Company, S1 Enterprises, Launches Largest Employee Stock Ownership Plan in U.S. Cannabis Industry
Kansas City, Missouri--(Newsfile Corp. - January 5, 2026) - S1 Enterprises, the parent company of the Illicit brand and affiliated cannabis operations in Missouri and New Jersey, has successfully closed on its sale to an Employee Stock Ownership Plan (ESOP), marking a major milestone for employee ownership in the regulated cannabis industry. This transaction represents the largest ESOP completed in the cannabis sector to date, reflecting both the scale of the company and growing institu
Cannabis, Cannabis Dispensary, Cannabis Extractor, Cannabis Manufacturer
2026-01-05 1:04 PM EST | Illicit Gardens
PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring
Toronto, Ontario--(Newsfile Corp. - January 5, 2026) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has closed the previously announced (see press release dated October 31, 2025) acquisition (the "Transaction") of limited partnership units of Canurta Limited Partnership ("Canurta"), the p
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2026-01-05 8:00 AM EST | PharmaDrug Inc.
Simply Solventless Announces Appointment of Seasoned Executive Charles Vennat to Board of Directors
Calgary, Alberta--(Newsfile Corp. - January 5, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to announce the appointment of seasoned executive Charles Vennat to its board of directors. Charles is an accomplished CEO and corporate director with significant experience leading complex manufacturing, consumer packaged goods and regulated cannabis businesses. Charles currently serves as President & CEO of CMI Mulching. Prior thereto,
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-01-05 7:05 AM EST | Simply Solventless Concentrates Ltd.
Steep Hill Provides Update on Transaction with Good Purpose Investments
Toronto, Ontario--(Newsfile Corp. - December 19, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") is pleased to provide an update on its ongoing transaction with Good Purpose Investments Inc. ("Good Purpose"). Good Purpose is a privately held British Columbia corporation that operates a business engaged in the manufacturing, marketing, and distribution of textiles made from recycled plastics under the trade name "Waste2Wear." Through its subs
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-12-19 5:30 PM EST | Steep Hill Inc.
Flora Growth Announces Results of 2025 Special Meeting of Shareholders
Fort Lauderdale, Florida--(Newsfile Corp. - December 19, 2025) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), which is set to rebrand as ZeroStack, and is the first public company to offer exposure to Decentralized AI through the accumulation of $0G, the native cryptocurrency of the distributed AI infrastructure project 0G ("$0G"), held its 2025 Special Meeting of Shareholders (the "Meeting"). The final voting results of the proposals submitted to a vote of the Company's sha
Cannabis, Cannabis Cultivator, Cannabis Manufacturer, Crypto
2025-12-19 4:33 PM EST | Flora Growth Corp.
Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States
Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") applauds the recent reports that US President Donald Trump and his administration are considering changes and the reclassification of federal cannabis policy in the USA, including potential rescheduling of cannabis from Schedule I to Schedule III. Schedule III drugs are considered to have a medical value and a lower abuse potential as defined by the Drug Enforcement Administra
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-12-18 7:30 AM EST | Akanda Corp